1. Executive Summary

2. United States Carrier Screening Volume & Forecast (2015 - 2026)

3. United States Carrier Screening Market Size & Forecast (2015 - 2026)

4. Key Drivers and Inhibitors of the United States Carrier Screening Market
4.1 Market Drivers
4.2 Inhibitors

5. Reimbursement Policies of the United States Carrier Screening

6. Regulation System of the United States Carrier Screening

7. Major Deals in the Carrier Screening Market
7.1 Collaboration Deals
7.2 Merger and Acquisitions
7.3 Distribution Agreement
7.4 Partnership Deals

8. Key Companies Analysis
8.1 Natera
8.1.1 Business Overview
8.1.2 Carrier Screening Test Portfolio
8.1.3 Carrier Screening - Latest Development & Trends
8.2 Myraid Genetics
8.2.1 Business Overview
8.2.2 Carrier Screening Portfolio
8.2.3 Carrier Screening - Latest Development & Trends
8.3 Luminex Corporation
8.3.1 Business Overview
8.3.2 Carrier Screening Portfolios
8.3.3 Carrier Screening - Latest Development & Trends
8.4 Integrated Genetics (LapCorp)
8.4.1 Business Overview
8.4.2 Carrier Screening Portfolios
8.4.3 Carrier Screening - Latest Development & Trends
8.5 Quest Diagnostics
8.5.1 Business Overview
8.5.2 Carrier Screening Portfolios
8.5.3 Carrier Screening - Latest Development & Trends
8.6 Thermo Fisher Scientific Inc.
8.6.1 Business Overview
8.6.2 Carrier Screening Portfolios
8.6.3 Carrier Screening - Latest Development & Trends
8.7 Centogene
8.7.1 Business Overview
8.7.2 Carrier Screening Portfolios
8.7.3 Carrier Screening - Latest Development & Trends
8.8 Invitae Corporation
8.8.1 Business Overview
8.8.2 Carrier Screening Portfolios
8.8.3 Carrier Screening - Latest Development & Trends
8.9 Otogenetics
8.9.1 Business Overview
8.9.2 Carrier Screening Portfolios
8.9.3 Carrier Screening - Latest Development & Trends
8.10 GenPath
8.10.1 Business Overview
8.10.2 Carrier Screening Portfolios
8.10.3 Carrier Screening - Latest Development & Trends
8.11 Progenity
8.11.1 Business Overview
8.11.2 Carrier Screening Portfolios
8.11.3 Carrier Screening - Latest Development & Trends
8.12 Fulgent Genetics
8.12.1 Business Overview
8.12.2 Carrier Screening Portfolios
8.12.3 Carrier Screening - Latest Development & Trends
8.13 GenMark Diagnostics
8.13.1 Business Overview
8.13.2 Carrier Screening Portfolios
8.13.3 Carrier Screening - Latest Development & Trends
8.14 Sema4
8.14.1 Business Overview
8.14.2 Carrier Screening Portfolios
8.14.3 Carrier Screening - Latest Development & Trends
8.15 Pathway Genomics
8.15.1 Business Overview
8.15.2 Carrier Screening Portfolios
8.15.3 Carrier Screening - Latest Development & Trends
8.16 Gene By Gene
8.16.1 Business Overview
8.16.2 Carrier Screening Portfolios
8.16.3 Carrier Screening - Latest Development & Trends